News

03.06.2025
Team MEGA at the IKK BB Berliner Firmenlauf 2025
Running together. Growing together. On May 21 2025 the streets of Berlin were filled with energy excitement and thousands of determined runners as the IKK BB Berliner Firmenlauf (Company Run) returned in full force. Team MEGA was proud to be part of this unforgettable event joining more than 20.000 participants in one of the most […]
More details

16.05.2025
Upcoming Symposium on Autoantibodies – Preliminary Programm
From September 9 to 12, 2025, the 17th Dresden Symposium on Autoantibodies will take place in Dresden, Germany. This year’s theme, “The Autoantibody Spectrum: Bridging Health, Diagnostics, and Disease,” brings together global experts for a deep dive into the evolving science of autoimmune diagnostics. The event also honors the legacy of Prof. Eng M. Tan, […]
More details

15.05.2025
Expanding Our Distribution Network in Germany
GA Generic Assays and Medipan are established diagnostic manufacturers based in Germany, known for quality, innovation, and scientific precision. Our diagnostic solutions are used both nationally and internationally, with a special focus on autoimmune diseases and specialized laboratory diagnostics. To complement our existing network and explore new regional opportunities, we are looking to expand our […]
More details

05.05.2025
Diagnostic Guidelines for Celiac Disease: Managing the Selective IgA Deficiency Challenge
Celiac disease (CD) diagnosis has advanced significantly over the past decade. Global guidelines now emphasize a combination of serology, genetics, and histology. While regional approaches differ, all aim for accurate diagnosis with minimal invasiveness. Core serological markers include antibodies against tissue transglutaminase (tTG), deamidated gliadin peptide (DG), and endomysial antibodies (EmA), assessed in both IgA […]
More details

09.04.2025
Join Medipan & GA Generic Assays at the Long Night of Business!
Das Antiphospholipid-Syndrom (APS) ist ein bedeutender Risikofaktor für Schwangerschaftskomplikationen, doch seine Diagnose bleibt eine Herausforderung. Jüngste Fortschritte in der APS-Diagnostik liefern tiefere Einblicke in seine Rolle bei wiederholtem Schwangerschaftsverlust und Präeklampsie. Durch innovative Biomarkerforschung und verfeinerte Testmethoden wird die Diagnosesicherheit verbessert, sodass Risikopatientinnen präziser identifiziert und gezielt behandelt werden können. Erfahren Sie mehr über die neuesten Entwicklungen in der APS-Diagnostik und deren Auswirkungen auf die mütterliche und fetale Gesundheit.
More details

26.03.2025
New Diagnostic Insights in Antiphospholipid Syndrome (APS) and Pregnancy
Antiphospholipid Syndrome (APS) is a major risk factor for pregnancy complications, yet diagnosing it remains challenging. Recent advancements in APS diagnostics provide deeper insights into its role in recurrent pregnancy loss and preeclampsia. Cutting-edge biomarker research and refined testing methods are improving accuracy, helping clinicians better identify at-risk patients and tailor treatment strategies. Discover the latest developments in APS diagnostics and their impact on maternal and fetal health.
More details

24.03.2025
Introducing our New Newsletter
Stay Ahead in Diagnostics and Subscribe to Our Medipan & GA Generic Assays‘ Newsletter In the fast-evolving field of diagnostics, staying informed is key. With the Medipan & GA Generic Assays newsletter, you gain exclusive access to our latest advancements, research insights, and innovative solutions in autoimmune and infectious disease diagnostics. Why Subscribe? As a […]
More details

04.03.2025
ICAP Update: Expansion of ANA Pattern Classification with AC-30 and AC-31
The International Consensus on ANA Patterns (ICAP) has taken another significant step in the continuous advancement to promote harmonization and understanding in antinuclear antibodies (ANA) of the HEp-2 IFA. As previously anticipated, in the ongoing update of the ANA pattern classification, two newly identified patterns, AC-30 and AC-31, have been incorporated into the ICAP nomenclature […]
More details

19.02.2025
Guillain-Barré Syndrome Outbreak: The Role of Anti-Ganglioside Antibodies Testing
A recent outbreak of Guillain-Barré Syndrome (GBS) in Pune, India, has seen approximately 160 reported cases since early January. The outbreak has been linked to Campylobacter jejuni, a foodborne pathogen and one of the leading causes of GBS worldwide [1]. Understanding Guillain-Barré Syndrome and Its Triggers GBS is a rare neurological autoimmune disease in which […]
More details

28.01.2025
Extended Shelf Life for Our RIA Kits for the determination of TSH, Tg, and Calcitonin
Extended Shelf Life for Our RIA Kits We are pleased to announce that our optimized production processes now ensure you receive RIA Kits SELco® TSH Rapid, SELco® Tg 1 Step, and SELco® Calcitonin with an extended shelf life of additional two weeks. Thanks to these improvements, we now complete the production process two weeks earlier, […]
More details